3 results
OX40 agonists have been shown to increase antitumor immunity and improve tumor-free survival in non-clinical models and OX40 agonist monoclonal antibodies (mAbs) are currently being evaluated in Phase I clinical trials. GSK3174998 is a humanized…
The purpose of this study is to compare the good and bad effects of bermekimab to the good and bad effects of adalimumab and/or placebo. Adalimumab is a drug already used to treat moderate to severe hidradenitis suppurativa (HS).
The primary goal of this research is to test the proof of concept of the functional prototype of the INES exoskeleton for children with CP in the clinic. In addition,the defined use cases (Donning, Doffing, Sit-to-stand, Stand to sit, Walk) will be…